USA flag logo/image

An Official Website of the United States Government

Search


Narrow Search Filters:
Agency:HHS
Year:20122011
Download to spreadsheetPrint
Displaying 2376 – 2397 of 2397 Awards
Company: PRESAGE BIOSCIENCES, INC. Agency/Program/Year/Phase: HHS / STTR / 2011 / 2
Abstract: DESCRIPTION (provided by applicant): Over 90% of cancer patients that enroll in Phase I or II clinical trials experience no benefit from the experimental therapies, yet are exposed to drug toxicity and other challenges related to treatment. For over 50 years, physicians have used patient-specific… more
Company: ANTIOP, INC. Agency/Program/Year/Phase: HHS / STTR / 2011 / 2
Abstract: DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR project proposes to apply drug delivery technologies to develop a novel use for a nasally delivered… more
Company: VIRTUAL PHANTOMS, INC. Agency/Program/Year/Phase: HHS / STTR / 2011 / 2
Abstract: DESCRIPTION (provided by applicant): This project aims to develop a commercial software product, VirtualDoseTM, for calculating and analyzing patient radiation doses from x-ray computed tomography (CT) examinations. Despite its essential role in radiology, CT is responsible for raising the… more
Company: MICRO VIDE, LLC Agency/Program/Year/Phase: HHS / STTR / 2011 / 2
Abstract: DESCRIPTION (provided by applicant): A major cause of morbidity and mortality in cardiovascular surgery is excessive bleeding post- operatively, which is commonly managed by pharmacologically modifying clot degradation (fibrinolysis), through inhibition of plasmin activity (PLact). However, the only… more
Company: GLIKNIK INC. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 2
Abstract: Background Information Rituxan and Herceptin are multi-billion dollar products that are useful in lymphoma and breast cancer. However, significant unmet medical need persists for certain populations such as recurrent indolent NHL, HER2 IHC 2+ patients, and treatment of patients with the FcgR3a 158… more
Company: PICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 2
Abstract: Under this SBIR Phase II project, the Contractor shall develop and evaluate their " Clinical Trial Participant Management System." This product will be comprehensive, integrated IVR phone and Web (email and text) delivered database system designed to facilitate the management of clinical… more
Company: GENOME EXPLORATIONS INC Agency/Program/Year/Phase: HHS / SBIR / 2011 / 2
Abstract: Alcohol abuse and its related health effects are estimated to have an economic cost in the US that approaches $200 Billion per year. However, current tests for alcohol use/abuse are not reliable except when administered within several hours of intoxication. Moreover, current clinical tests for… more
Company: OPEN SOURCE MEDICAL SOFTWARE CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2011 / 2
Abstract: Develop a repository of human cardiovascular and cardiopulmonary computer models consisting of realistic, image-based anatomic models of large arteries and airways, generic, distal vascular beds, and representative blood and tissue properties. Simulationsbased on repository data will have… more
Company: SID TECHNOLOGIES LLC Agency/Program/Year/Phase: HHS / SBIR / 2011 / 2
Abstract: SID Technologies is developing intradermal devices aiding healthcare workers in performing intradermal injections. The goal is to provide an alternative, easier to learn method of intradermal drug delivery to the Mantoux technique, in order to expand the population of healthcare workers who may… more
Company: Applied Decision Science, LLC Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: There is a need for better decision support tools to help doctors quickly assess patients' cancer screening status. Colorectal cancer screening is especially difficult to track because there are many screening options that take place over time and in different settings. The proposed research will… more
Company: ChromoLogic LLC Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: Accurately detecting early cancer biomarkers can dramatically improve cancer treatment and prevention. Non-coding RNAs (ncRNAs) have recently shown promise as cancer-related biomarkers that could be used in early detection and treatment of cancer. However,current methods for detection of ncRNAs are… more
Company: VISTA ENGINEERING, INC. Agency/Program/Year/Phase: HHS / STTR / 2011 / 2
Abstract: DESCRIPTION (provided by applicant): Temporomandibular Disorders (TMD) represent a collection of medical and dental conditions affecting the temporomandibular joint (TMJ) and/or the muscles of mastication, as well as contiguous tissue structures. For somepatients with severe TMJ degeneration, a… more
Company: Lynntech, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): Vapor intrusion is the migration of volatile chemicals from the subsurface into overlying buildings, one of the major causes for a large population exposure to hazardous chemicals. These volatile chemicals are often theresult of buried waste and/or contaminated… more
Company: Lynntech, Inc. Agency/Program/Year/Phase: HHS / STTR / 2011 / 2
Abstract: DESCRIPTION (provided by applicant): Research and development of new drugs is a protracted and expensive endeavor. The typical drug discovery process evolves from lead identification for a disease target to lead optimization, in vitro/in vivo evaluation, preclinical and clinical testing, and FDA… more
Company: Lynntech, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): Catheter-associated urinary tract infections (CAUTI) occur in gt40and of the 21-50% patients that are administered indwelling catheters, annually costing a staggering 421- 451 million in medical intervention, antimicrobial treatments and frequent catheter… more
Company: Lynntech, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): Food-borne toxins such as mycotoxins and gossypol continue to impact human health in diverse ways, including negative effects on reproduction, neurological function, developmental biology, renal and respiratory function, susceptibility to infectious disease, and… more
Company: Lynntech, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): According to the CDC, chlamydia and gonorrhea, caused by Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), respectively, are the first and second most frequently reported STIs in the US and likely the rest of the world. These STIs are often… more
Company: Parabon NanoLabs, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): In this Phase I SBIR project, Parabon NanoLabs, Inc. (PNL) will produce a novel, nano- pharmaceutical compound that preferentially selects and destroys brain tumor stem cells (BTSCs) to aid the treatment of glioblastomamultiforme (GBM), one of the most lethal… more
Company: Physical Sciences Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): Physical Sciences Inc. (PSI) proposes to develop a new adaptive optics imaging approach to high- speed 3D-retinal mapping with enhanced Fourier Domain Mode-locked (FDML) swept-source technology. PSI is currently engaged in ongoing development of high… more
Company: Physical Sciences Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): Improper or incomplete sterilization of manufacturing facilities is a major cause of pharmaceutical product recalls. The economic and societal impact of these recalls is significant and difficult to quantify. Many pharmaceutical companies use vapor phase hydrogen… more
Company: TDA Research, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): In this Phase I SBIR project, TDA Research, Inc. will develop a compact, lightweight portable oxygen concentrator (POC) for medical operations and carry out a breadboard demonstration to produce continuous flow of enriched oxygen (O2) from ambient air. The new… more
Company: TDA Research, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2011 / 1
Abstract: DESCRIPTION (provided by applicant): Sorbents for Toxic-Metal Removal in Pharmaceutical Development and Manufacture SBIR Phase I Application P.I.: Girish Srinivas, TDA Research, Inc. The overall project goal is to minimize toxic impurities in pharmaceuticals that arise during drug synthesis. Toxic… more
Displaying 2376 – 2397 of 2397 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.